Clinical trial
Lofexidine Pharmacokinetics in the Presence of Paroxetine, a Strong CYP2D6 Inhibitor, in Healthy Volunteers
NCT02681198 is registered in ClinicalTrials.gov with USWM, LLC (dba US WorldMeds) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lofexidine Pharmacokinetics in the Presence of Paroxetine, a Strong CYP2D6 Inhibitor, in Healthy Volunteers
- Lead sponsor
- USWM, LLC (dba US WorldMeds)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- March 31, 2016
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy